83.88 USD
+0.56 (+0.67%)
At close: Feb 10, 2026
83.88 USD
0 (0%)
Pre-Market: 2/11/2026, 4:32:22 AM
ChartMill assigns a Buy % Consensus number of 84% to PTGX. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 102.55. This target is 22.26% above the current price.
- PTGX was analyzed by 19 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about PTGX.
- In the previous month the buy percentage consensus was at a similar level.
- PTGX was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-02 | Jefferies | Maintains | Buy -> Buy |
| 2026-01-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-05 | Truist Securities | Maintains | Buy -> Buy |
| 2025-12-17 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-08 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-10 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-07 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-11-07 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-07 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-28 | BTIG | Reiterate | Buy -> Buy |
| 2025-10-28 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-10-28 | Truist Securities | Maintains | Buy -> Buy |
| 2025-10-17 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-17 | Barclays | Initiate | Overweight |
| 2025-09-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-12 | Leerink Partners | Initiate | Outperform |
| 2025-08-07 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-06-17 | Citigroup | Initiate | Buy |
| 2025-06-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-28 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-03-11 | BMO Capital | Reiterate | Outperform -> Outperform |
| 2025-03-11 | Truist Securities | Maintains | Buy -> Buy |
| 2025-03-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-10 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-03-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-04 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-03-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
PROTAGONIST THERAPEUTICS INC / PTGX FAQ
What do analysts expect the price target to be for PROTAGONIST THERAPEUTICS INC (PTGX)?
19 analysts have analysed PTGX and the average price target is 102.55 USD. This implies a price increase of 22.26% is expected in the next year compared to the current price of 83.88.
What is the consensus rating for PTGX stock?
The consensus rating for PROTAGONIST THERAPEUTICS INC (PTGX) is 84.2105 / 100 . This indicates that analysts generally have a positive outlook on the stock.